Dr. Perlroth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
192 Corte Madera Rd
Portola Valley, CA
Portola Valley, CA 94028Phone+1 650-851-8184
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1965 - 1967
Clinical Center at the National Institutes of HealthResidency, Internal Medicine, 1963 - 1965
Brigham and Women's HospitalResidency, Internal Medicine, 1960 - 1962
Harvard Medical SchoolClass of 1960
Certifications & Licensure
CA State Medical License 1965 - 2021
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 55 citationsAcute intermittent porphyria: New morphologic and biochemical findingsMark G. Perlroth, Donald P. Tschudy, Harvey S. Marver, Costan W. Berard, Robert F. Zeigel
The American Journal of Medicine. 1966-07-01 - 124 citationsACUTE INTERMITTENT PORPHYRIA: THE FIRST "OVERPRODUCTION DISEASE" LOCALIZED TO A SPECIFIC ENZYME.Donald P. Tschudy, Mark G. Perlroth, Harvey S. Marver, Annie Collins, George J. Hunter
Proceedings of the National Academy of Sciences of the United States of America. 1965-04-01 - 27 citationsEffect of rapamycin therapy on coronary artery physiology early after cardiac transplantation.Seema Sinha, M.X. Pham, Randall H. Vagelos, Mark G. Perlroth, Sharon A. Hunt
American Heart Journal. 2008-05-01
Grant Support
- Cyclosporin A Nephrotoxicity &Hypertension After Cardiac TransplantationNational Center For Research Resources1985
Professional Memberships
- Member
Other Languages
- French, Italian, German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
